0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Carbapenem-resistant Enterobacteriaceae Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-23S4001
Home | Market Reports | Science| Biological Sciences
Global Carbapenem resistant Enterobacteriaceae Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Carbapenem-resistant Enterobacteriaceae Testing Market Research Report 2025

Code: QYRE-Auto-23S4001
Report
September 2025
Pages:64
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Carbapenem-resistant Enterobacteriaceae Testing Market

The global market for Carbapenem-resistant Enterobacteriaceae Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Enterobacteriaceae are a family of germs that most commonly live in a person’s bowel without causing any disease. Carbapenems are strong antibiotics that are commonly used to treat serious infections. A few enterobacteriaceaea have gained resistance to these antibiotics. These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae testing is considered to be a gram-negative pathogen testing. Common gram-negative pathogens include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumonia, Enterobacter aerogenes and Acinetobacterbaumannii.
North American market for Carbapenem-resistant Enterobacteriaceae Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Carbapenem-resistant Enterobacteriaceae Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Carbapenem-resistant Enterobacteriaceae Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Carbapenem-resistant Enterobacteriaceae Testing include TBA, SolGent, ELITechGroup, ALIFAX, BioMérieux, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem-resistant Enterobacteriaceae Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-resistant Enterobacteriaceae Testing.
The Carbapenem-resistant Enterobacteriaceae Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Carbapenem-resistant Enterobacteriaceae Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem-resistant Enterobacteriaceae Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Carbapenem-resistant Enterobacteriaceae Testing Market Report

Report Metric Details
Report Name Carbapenem-resistant Enterobacteriaceae Testing Market
Segment by Type
  • Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
  • Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
  • Other Types
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company TBA, SolGent, ELITechGroup, ALIFAX, BioMérieux
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Carbapenem-resistant Enterobacteriaceae Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Carbapenem-resistant Enterobacteriaceae Testing Market report?

Ans: The main players in the Carbapenem-resistant Enterobacteriaceae Testing Market are TBA, SolGent, ELITechGroup, ALIFAX, BioMérieux

What are the Application segmentation covered in the Carbapenem-resistant Enterobacteriaceae Testing Market report?

Ans: The Applications covered in the Carbapenem-resistant Enterobacteriaceae Testing Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Carbapenem-resistant Enterobacteriaceae Testing Market report?

Ans: The Types covered in the Carbapenem-resistant Enterobacteriaceae Testing Market report are Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing, Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing, Other Types

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
1.2.3 Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Perspective (2020-2031)
2.2 Global Carbapenem-resistant Enterobacteriaceae Testing Growth Trends by Region
2.2.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Region (2020-2025)
2.2.3 Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Region (2026-2031)
2.3 Carbapenem-resistant Enterobacteriaceae Testing Market Dynamics
2.3.1 Carbapenem-resistant Enterobacteriaceae Testing Industry Trends
2.3.2 Carbapenem-resistant Enterobacteriaceae Testing Market Drivers
2.3.3 Carbapenem-resistant Enterobacteriaceae Testing Market Challenges
2.3.4 Carbapenem-resistant Enterobacteriaceae Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Revenue
3.1.1 Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Revenue (2020-2025)
3.1.2 Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Players (2020-2025)
3.2 Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Carbapenem-resistant Enterobacteriaceae Testing Revenue
3.4 Global Carbapenem-resistant Enterobacteriaceae Testing Market Concentration Ratio
3.4.1 Global Carbapenem-resistant Enterobacteriaceae Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carbapenem-resistant Enterobacteriaceae Testing Revenue in 2024
3.5 Global Key Players of Carbapenem-resistant Enterobacteriaceae Testing Head office and Area Served
3.6 Global Key Players of Carbapenem-resistant Enterobacteriaceae Testing, Product and Application
3.7 Global Key Players of Carbapenem-resistant Enterobacteriaceae Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Carbapenem-resistant Enterobacteriaceae Testing Breakdown Data by Type
4.1 Global Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Type (2020-2025)
4.2 Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Type (2026-2031)
5 Carbapenem-resistant Enterobacteriaceae Testing Breakdown Data by Application
5.1 Global Carbapenem-resistant Enterobacteriaceae Testing Historic Market Size by Application (2020-2025)
5.2 Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size (2020-2031)
6.2 North America Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025)
6.4 North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size (2020-2031)
7.2 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025)
7.4 Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size (2020-2031)
8.2 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size (2020-2031)
9.2 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025)
9.4 Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size (2020-2031)
10.2 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 TBA
11.1.1 TBA Company Details
11.1.2 TBA Business Overview
11.1.3 TBA Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.1.4 TBA Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
11.1.5 TBA Recent Development
11.2 SolGent
11.2.1 SolGent Company Details
11.2.2 SolGent Business Overview
11.2.3 SolGent Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.2.4 SolGent Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
11.2.5 SolGent Recent Development
11.3 ELITechGroup
11.3.1 ELITechGroup Company Details
11.3.2 ELITechGroup Business Overview
11.3.3 ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.3.4 ELITechGroup Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
11.3.5 ELITechGroup Recent Development
11.4 ALIFAX
11.4.1 ALIFAX Company Details
11.4.2 ALIFAX Business Overview
11.4.3 ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.4.4 ALIFAX Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
11.4.5 ALIFAX Recent Development
11.5 BioMérieux
11.5.1 BioMérieux Company Details
11.5.2 BioMérieux Business Overview
11.5.3 BioMérieux Carbapenem-resistant Enterobacteriaceae Testing Introduction
11.5.4 BioMérieux Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
11.5.5 BioMérieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing
 Table 3. Key Players of Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing
 Table 4. Key Players of Other Types
 Table 5. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region (2020-2025)
 Table 9. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region (2026-2031)
 Table 11. Carbapenem-resistant Enterobacteriaceae Testing Market Trends
 Table 12. Carbapenem-resistant Enterobacteriaceae Testing Market Drivers
 Table 13. Carbapenem-resistant Enterobacteriaceae Testing Market Challenges
 Table 14. Carbapenem-resistant Enterobacteriaceae Testing Market Restraints
 Table 15. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Players (2020-2025)
 Table 17. Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-resistant Enterobacteriaceae Testing as of 2024)
 Table 18. Ranking of Global Top Carbapenem-resistant Enterobacteriaceae Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Carbapenem-resistant Enterobacteriaceae Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Carbapenem-resistant Enterobacteriaceae Testing, Headquarters and Area Served
 Table 21. Global Key Players of Carbapenem-resistant Enterobacteriaceae Testing, Product and Application
 Table 22. Global Key Players of Carbapenem-resistant Enterobacteriaceae Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Carbapenem-resistant Enterobacteriaceae Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Carbapenem-resistant Enterobacteriaceae Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. TBA Company Details
 Table 48. TBA Business Overview
 Table 49. TBA Carbapenem-resistant Enterobacteriaceae Testing Product
 Table 50. TBA Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025) & (US$ Million)
 Table 51. TBA Recent Development
 Table 52. SolGent Company Details
 Table 53. SolGent Business Overview
 Table 54. SolGent Carbapenem-resistant Enterobacteriaceae Testing Product
 Table 55. SolGent Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025) & (US$ Million)
 Table 56. SolGent Recent Development
 Table 57. ELITechGroup Company Details
 Table 58. ELITechGroup Business Overview
 Table 59. ELITechGroup Carbapenem-resistant Enterobacteriaceae Testing Product
 Table 60. ELITechGroup Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025) & (US$ Million)
 Table 61. ELITechGroup Recent Development
 Table 62. ALIFAX Company Details
 Table 63. ALIFAX Business Overview
 Table 64. ALIFAX Carbapenem-resistant Enterobacteriaceae Testing Product
 Table 65. ALIFAX Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025) & (US$ Million)
 Table 66. ALIFAX Recent Development
 Table 67. BioMérieux Company Details
 Table 68. BioMérieux Business Overview
 Table 69. BioMérieux Carbapenem-resistant Enterobacteriaceae Testing Product
 Table 70. BioMérieux Revenue in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025) & (US$ Million)
 Table 71. BioMérieux Recent Development
 Table 72. Research Programs/Design for This Report
 Table 73. Key Data Information from Secondary Sources
 Table 74. Key Data Information from Primary Sources
 Table 75. Authors List of This Report


List of Figures
 Figure 1. Carbapenem-resistant Enterobacteriaceae Testing Picture
 Figure 2. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Type: 2024 VS 2031
 Figure 4. Modified Hodge Carbapenem-resistant Enterobacteriaceae Testing Features
 Figure 5. Minimal Inhibitory Concentration Carbapenem-resistant Enterobacteriaceae Testing Features
 Figure 6. Other Types Features
 Figure 7. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Application: 2024 VS 2031
 Figure 9. Hospitals Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Others Case Studies
 Figure 12. Carbapenem-resistant Enterobacteriaceae Testing Report Years Considered
 Figure 13. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Carbapenem-resistant Enterobacteriaceae Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Carbapenem-resistant Enterobacteriaceae Testing Market Share by Players in 2024
 Figure 17. Global Top Carbapenem-resistant Enterobacteriaceae Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-resistant Enterobacteriaceae Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Carbapenem-resistant Enterobacteriaceae Testing Revenue in 2024
 Figure 19. North America Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2020-2031)
 Figure 21. United States Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2020-2031)
 Figure 25. Germany Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Carbapenem-resistant Enterobacteriaceae Testing Market Share by Region (2020-2031)
 Figure 33. China Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Carbapenem-resistant Enterobacteriaceae Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Carbapenem-resistant Enterobacteriaceae Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. TBA Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
 Figure 49. SolGent Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
 Figure 50. ELITechGroup Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
 Figure 51. ALIFAX Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
 Figure 52. BioMérieux Revenue Growth Rate in Carbapenem-resistant Enterobacteriaceae Testing Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India